Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT00422006
NA

Study of the Role of PCSK9 and FXR in the Physiopathology of the Joint Dyslipidemia Associated to the Human Immunoresistance

Sponsor: Nantes University Hospital

View on ClinicalTrials.gov

Summary

Experimental results are strongly suggesting that PCSK9 and FXR could occur in the physiopathology of human joined dyslipidemia. But no data in the literature can validate the potential role of these two genes in the lipidic and glucidic metabolism control in physiopathological situations. This protocol is based on the hypothesis that the expression levels of PCSK 9 and FXR are modified for some patients suffering from insulin resistance and dyslipidemia.

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

111

Start Date

2008-02

Completion Date

2013-11

Last Updated

2026-09-14

Healthy Volunteers

No

Conditions

Interventions

PROCEDURE

biopsy of muscle, of liver, and of adipose tissue

biopsy of muscle, of liver, and of adipose tissue

PROCEDURE

clamp euglycemic - hyperglycemic

clamp euglycemic-hyperglycemic

BEHAVIORAL

diet

diet

OTHER

biopsies for biological and genetic analyses

biopsies for biological and genetic analyses

Locations (1)

CHU de Nantes

Nantes, France